Jan is almost over. Normally, doesn't RMTI announce the Feb conf.call date in late January?
I'm eager to hear from Rob and get an update instead of reading nonsense on this board
I sure hope that you are correct. Eventually, the price of crude will turn up again and I doubt that a lot of the frackers will rush back in knowing that Saudi Arabia can open the valve any time
I've been in RMTI for over 3 years now. Regardless of what the pumpers or bashers on this board say, it is a small biotech with its future pretty much tied to Triferic. Triferic gained FDA approval in January (from memory). I know that it takes time to work on contracts, manufacturing, etc. I get it, but the reality is there are only 8 bigger customers with 4 much bigger. Rob started the company but he treats it as his instead of a publicly traded entity. I listened to the CC a couple of times and still am not sure where we stand I was hoping for a lot more detail. I'm still giving Rob the benefit of the doubt, but if we don't get a couple of more Triferic contracts inked and a Calcitriol launch by the next CC, it will be very discouraging.
Yesterday's fleet status report did not bring any new contracts. In fact it highlighted the fact that day rates will continue to be under pressure (Saudi Aramco). There needs to be a lot more rigs cold stacked in the entire industry to bring the supply/demand dynamics for rigs back into equilibrium. Unless OPEC and Russia agree to supply cuts, I don't see much hope for crude oil going up a lot. Without higher crude prices, there will continue to be exploration capex cuts by the majors.
Something has to give but right now it does not look good for the off shore drillers
Could you give it a rest. You have been an oil bull for a long time and you have lost a ton of money. We all know that oil is ridiculously low, yet it continues to go down. No one knows where the final bottom is and your relentless posts lacking the minimum content serve no positive benefit
PRICE TARGET CALCULATION
We use a sum-of-the parts analysis to value RMTI shares. Our 12- to 18-month target price of $26 is derived by summing up the following components of its development programs: the estimated risk-adjusted net present value of Triferic at ~$1B (or $20/share), the estimated risk-adjusted NPV of Calcitriol at ~$193M (~$4/share), and the existing business, valued at ~$100M ($2/share).
■ Financing risk: RMTI may need to raise additional capital in the near future, potentially causing dilution for shareholders.
■ Commercialization risks: The market potential and penetration of RMTI's product candidates, especially Triferic and Calcitriol, may not be as large as our projections.
■ High stock price volatility: High stock price volatility is common among developmental companies in the biotechnology sector.
I listened to the CC twice and admit that I am still confused. I posted the Oppenheimer details earlier today. If you read her entire write up, she has uncertainty issues in several places. I still don't understand how profitable with bundled pricing that Triferic will be. Also, what kind of introductory discounts are going to be given? I suppose that we just have to wait. I do think that there will continue to have a lot of price volatility until we get more facts about Triferic sales and profitability
I think you have it right. RIG will not buy Noble or anyone else unless they get the company at extremely distressed prices. NE is probably the strongest driller and will not be acquired at a bargain. It makes more sense that RIG will have more luck will leases
Yes NE has 2 rigs with FCX in the GOM. You are correct that there is more capacity coming into the market during 2016. There definitely will be lower day rates for 2016. The SLB CEO stated today that off shore drilling won't pick up before 2017...he's right.
To make money, I am selling into all price spikes and buying back on the dips. My goal is to make $.75-$1/share with each round trip trade. I'll try to buy my shares back next week for
If they hit your low end, that would be great as nit is far higher than the street estimates right now
I used to work in Accounting/Finance for a big pharma. company. These small pharma. companies have a lot riding on a small number of products. If Triferic sales take off, a big player will probably buy out RMTI. Last Summer, I decided to take a lot of risk off the table and sold 1/2 of my shares at 14...the price then went up to $18+ after I sold and now Wall Street has pushed it back to $10.50ish. You need Triferic sales contracts to move it up and until we know what the likely 2016 Triferic profits will be, I don't see a catalyst out there to move the needle upward. I want to hear from RMTI mgmt in Feb and will then decide if I will hold/sell my remaining position
when we have continue to see the share price hitting concurrent new 52 week lows...as it did again today.
I'm still positive on the Triferic, but I'm starting to lose some confidence in Rob's ability to sell it. There are only 8 major (4 primarily) buyers. Why can't he close some sales contracts if Triferic is as revolutionary and less costly as it is purported to be. I realize that the steadfast bulls, like Duct tape, will come on and say that it is a great buying opportunity, but they have been saying this for months and the price keeps going down. If they would have waited, they could have purchased it a lot cheaper
I've owned a fairly large position for a long time, but this price action is starting to make me question the real sales potential for Triferic. I hope that Rob gives us some good news and we see the share price spike up to new highs , but right now it is hard to be positive because the market usually knows the true value of a company
How is not disclosing who the customer is going to compromise their business. Triferic is supposed to be a revolutionary new dialysis product and why wouldn't you want everyone to know who the customer is.
Why haven't more sales contracts been announced? Is that going to jeopardize the shareholders?
I'm not bashing nor pumping. I just would like some basics facts. Rob still runs this company as if it was privately held. He gives the minimum information at quarterly conference calls and I hope that the analysts push him for more information next month.
If it is just a matter of needing more time to negotiate sales agreements, this is an understandable reason for having a delay in new executed contracts. If there are other reasons, the share price will continue to flounder
Vale has dropped from $35 in Dec 2010 to $3. I still don't see much hope for the industry to recover in 2016. Fortunes have been wiped out if you were invested in commodity stocks. I'd like to buy back into Vale, but don't see a turnaround in profits for a long time
It already has and I don't understand why
I still await the Feb CC and want to get a little feedback from Rob about both Triferic and Calcitriol
Why haven't we had a Calcitriol launch yet?
Why is it taking so long for Triferic to be used in the market place following Jan 2015 FDA approval?
That is not whining. That is someone looking for answers and the RMTI CEO does not give much content in his quarterly conference calls. The current price tells you what the market thinks about the stock. I want the price to go up so I can get out..nothing more
I'm hoping for some positive news to push the price back up and I'm gone